Form 4: Tevogen Bio Holdings Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Neal Flomenberg, Chief Scientific Officer of Tevogen Bio Holdings, sold shares to cover tax obligations related to vesting of restricted stock units.
Summary
- On October 17, 2024, Neal Flomenberg, the Chief Scientific Officer and Global R&D Lead of Tevogen Bio Holdings Inc. (TVGN), sold 1,078,600 shares of common stock.
- The sales were executed to satisfy tax obligations related to the vesting and settlement of restricted stock units.
- The shares were sold at a weighted average price of $1.62, with individual transactions ranging from $1.50 to $1.74.
- Following the transaction, Flomenberg directly owns 4,254,302 shares of Tevogen Bio Holdings Inc.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine transaction to cover tax obligations; no indication of positive or negative outlook.
Industry Context
This is a routine Form 4 filing, indicating an insider transaction. It's common for executives to sell shares to cover tax obligations when restricted stock units vest.
Key Dates
| Date | Description |
|---|---|
| 10/17/2024 | Date of stock sale transaction. |
| 10/18/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.